Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

50 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 22, 2025Jan 22 2:36 PMROTE WILLIAM E.
Proposed Sale
2,437$19.46$47.4K

View →

Dec 26, 2024Dec 26 9:13 PMSANDRA CALVIN
Proposed Sale
15,000$17.22$258.3K

View →

Nov 25, 2024Nov 25 10:59 PMCalvin Sandra
Proposed Sale
12,090$18.30$221.3K

View →

Oct 4, 2024Oct 4 8:21 PMGARY A LYONS
Proposed Sale
40,000$13.65$546.0K

View →

Sep 30, 2024Sep 30 8:22 PMJEFFREY MECKLER
Proposed Sale
40,000$14.06$562.3K

View →

Sep 11, 2024Sep 11 10:29 PMCalvin Sandra
Proposed Sale
15,000$14.80$222.0K

View →

Sep 9, 2024Sep 9 2:54 PMREED ELIZABETH E
Proposed Sale
4,387$11.52$50.5K

View →

Sep 9, 2024Sep 9 2:35 PMROTE WILLIAM E.
Proposed Sale
4,387$11.52$50.5K

View →

Sep 9, 2024Sep 9 2:34 PMDube Eric M
Proposed Sale
21,125$11.52$243.4K

View →

← Previous

Page 8 of 8

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 31, 2026Feb 4 2:30 AMWilliam E. RoteChief Research Officer
Grant/Award
53,570$33.1053,570(D)

View →

Jan 31, 2026Feb 4 2:30 AMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Grant/Award
20,160$33.1020,160(D)

View →

Jan 31, 2026Feb 4 2:30 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
66,960$33.1066,960(D)

View →

Jan 27, 2026Jan 28 1:25 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
51,865$15.46120,000(D)

View →

Jan 23, 2026Jan 28 1:25 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
8,135$15.46171,865(D)

View →

Jan 20, 2026Jan 21 9:05 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$19.0830,000(D)

View →

← Previous

Page 3 of 3